Press release
Biosimilar Growth Hormones Market Size, Trends, Growth, Outlook 2024-2033
Biosimilar Growth Hormones Market
The Business Research Company offers in-depth market insights through Biosimilar Growth Hormones Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The biosimilar growth hormones market size has grown strongly in recent years. It will grow from $0.76 billion in 2023 to $0.82 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to rising demand for growth hormones, patent expirations, clinical evidence, increasing clinical trials.
The biosimilar growth hormones market size is expected to see strongly grown in the next few years. It will grow to $1.19 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to pediatric growth disorders, expanding indications,increase in the diagnosis, increased awareness biosimilar options. Major trends in the forecast period include pediatric-focused biosimilars, biosimilar combinations, dosing convenience, biosimilar combinations, dosing convenience.
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=3391&type=smp
Market Segmentation:
The biosimilar growth hormones market covered in this report is segmented -
1) By Route Of Administration: Intravenous, Subcutaneous, Intramuscular, Oral
2) By Application: Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader Willi Syndrome, Other Applications
3) By Distribution Channel: Hospital And Retail Pharmacy, Online Pharmacy/ePharmacy, Speciality Clinics
Major Driver - Rising Incidence Of Childhood Growth Hormone Deficiency Spurs Global Biosimilar Growth Hormone Market
The growing number of children suffering from growth hormone deficiency is driving the growth of the global biosimilar growth hormone market. Growth hormone deficiency is caused by damage to the pituitary gland or hypothalamus, which may be the result of an abnormal formation that occurred before the child was born (congenital) or something that occurred during or after birth (acquired). Growth hormone deficiency has been identified in about 1 in every 3,800 babies. Additionally, some children acquire it later in life as a result of a brain tumor, brain operation, radiation therapy, injury, or infection. Thus, an increase in the number of children suffering from growth deficiencies drives the growth of the biosimilar growth hormones industry.
Competitive Landscape:
Major companies operating in the biosimilar growth hormones market include Amega Biotech, Biosidus S.A., Eli Lilly and Company, Ferring Pharmaceuticals, Genetech Inc., Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Sanofi S.A., USV Private Limited, Zhongshan Hygene Biopharm Co. Ltd., Biopartners And LG Chem, Boehringer Ingelheim International GmbH, Celltrion Inc., Coherus BioSciences Inc., Daiichi Sankyo Company Ltd., Dr. Reddy's Laboratories Ltd., Gedeon Richter Plc., Genor Biopharma Co. Ltd., GenScript Biotech Corporation, Hetero Drugs Limited, Intas Pharmaceuticals Ltd., LG Chem Ltd., Lupin Limited, Mabion S.A., Mundipharma International Limited, Oncobiologics Inc., Panacea Biotec Limited, Pfenex Inc., PlantForm Corporation
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/biosimilar-growth-hormone-global-market-report
Top Trend - Advancements In Rdna Technology Transforming Biosimilar Growth Hormone Production For Greater Affordability
Recombinant DNA technology (rDNA technology) is increasingly being implemented in the biosimilar growth hormone industry. The development of biosimilar growth hormone by using recombinant DNA technology (rDNA technology) is an emerging trend. For instance, in February 2021, Pfizer Inc., a US-based pharmaceutical company announced the initiation of Phase III clinical trial to evaluate the efficacy and safety of somatropin in a cohort of Japanese participants with Prader-Willi Syndrome (PWS). Somatropin, a growth hormone, is administered to address growth hormone deficiency (GHD) in children. The trial, on the other hand, is a multicenter, open-label, multi-cohort study.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Biosimilar Growth Hormones Market Characteristics
3. Biosimilar Growth Hormones Market Trends And Strategies
4. Biosimilar Growth Hormones Market - Macro Economic Scenario
5. Biosimilar Growth Hormones Market Size And Growth
…..
27. Biosimilar Growth Hormones Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biosimilar Growth Hormones Market Size, Trends, Growth, Outlook 2024-2033 here
News-ID: 3433198 • Views: …
More Releases from The Business research company
Leading Companies Fueling Innovation and Growth in the Private Network Services …
The private network services sector is set to experience remarkable growth as demand for secure, high-performance connectivity continues to rise across various industries. With advancements in wireless technology and evolving network needs, this market is positioning itself for widespread adoption and innovation over the coming years. Let's explore the market size, key players, driving trends, and segmentation to better understand what lies ahead.
Private Network Services Market Size and Growth Outlook…
In-Depth Examination of Segments, Industry Trends, and Key Competitors in the Po …
The policy control function as a service (PCFaaS) market is on track for substantial expansion over the coming years, driven by technological advancements and increasing demand in telecommunications. This sector is transforming rapidly as operators adapt to next-generation network requirements and cloud-native approaches. Let's delve into the market's expected valuation, key players, emerging trends, and notable segmentations shaping its future.
Significant Growth Forecast for the Policy Control Function As A Service…
Top Players and Competitive Dynamics in the Packet Optical Platform Market
The packet optical platform market is positioned for significant expansion in the coming years, driven by advances in network technology and increasing demand for high-capacity data transmission. As digital infrastructure evolves, this sector is set to play a crucial role in supporting the growing needs of data centers, telecom providers, and cloud services. Let's explore the market's projected size, key players, emerging trends, and the segments contributing to its growth.
Forecasted…
Analysis of Segmentation, Market Trends, and Competitive Landscape in the Open S …
The open source help desk software market is set to experience significant expansion in the coming years, driven by technological advancements and evolving business needs. As organizations increasingly embrace digital customer support, this market is positioned for notable growth through 2030. Below is an in-depth exploration of the market size, leading players, key trends, and segmentation insights.
Projected Market Size and Growth Rate of the Open Source Help Desk Software Market…
More Releases for Hormone
Surge In Hormone Imbalance Disorders Fuels Growth Of Hormone Therapy Market Emer …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Is the Expected CAGR for the Hormone Therapy Market Through 2025?
The size of the hormone therapy market has experienced significant growth in the past few years. It is expected to increase from $19.7 billion in 2024 to $21.1 billion in 2025, at a compound annual growth rate (CAGR) of 7.1%. The growth…
Parathyroid Hormone Market Overview: How Parathyroid Hormone Affects Health & Cl …
Parathyroid Hormone Market is predicted to grow at a CAGR 3.4% during the forecast period (2024-2031).
Parathyroid Hormone Market Report by DataM Intelligence delivers deep insights and analysis into the latest market trends, growth opportunities, and emerging challenges. Designed to help businesses make smarter, faster decisions, our reports combine both data-driven analysis and expert perspectives. At DataM Intelligence, we're committed to turning complex market landscapes into clear, actionable strategies so…
Estrogen Hormone Replacement: A Vital Segment Driving Growth in the Hormone Repl …
The Hormone Replacement Therapy (HRT) market is experiencing renewed interest, driven by an aging population and a growing understanding of hormonal health. Within this market, the estrogen hormone replacement segment stands out as a high-opportunity area, offering relief from menopausal symptoms and addressing various health concerns.
Market Dynamics and Growth Drivers
Estrogen HRT plays a crucial role in managing menopausal symptoms, such as hot flashes, night sweats, and vaginal dryness. Beyond symptom…
Klinefelter Syndrome Hormone Therapy Market - Balancing Hormones, Unleashing Pot …
Newark, New Castle, USA: The "Klinefelter Syndrome Hormone Therapy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Klinefelter Syndrome Hormone Therapy Market: https://www.growthplusreports.com/report/klinefelter-syndrome-hormone-therapy-market/8775
This latest report researches the…
Human Growth Hormone Market - Elevating Lives, Amplifying Growth: Innovations in …
Newark, New Castle, USA - new report, titled Human Growth Hormone Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Human Growth Hormone market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Human Growth Hormone market. The report offers an overview of…
Hormone Replacement Therapy Market Report- Segment by Application Menopause, Hyp …
The Hormone Replacement Therapy Market research report presents an intensive and coordinated exploration of the current circumstance, market key elements, Hormone Replacement Therapy Market methodologies, and central participants' development in the business. The investigation helps controllers and corporate leaders in developing cost-effective decisions. Hormone Replacement Therapy Market provides an evenhanded and extensive assessment of existing examples, factors, obstacles, limits, headway, possibilities/quick development areas that will help partners create business plans…
